Volume 17, Issue 2, Pages (February 2013)

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Volume 152, Issue 5, Pages e6 (April 2017)
A Helping Hand for Cytochrome P450 Enzymes
Volume 153, Issue 3, Pages (September 2017)
Volume 16, Issue 5, Pages (November 2012)
Ulrich Beuers, Michael Trauner, Peter Jansen, Raoul Poupon 
Volume 2, Issue 4, Pages (October 2005)
Bo Angelin, Tobias E. Larsson, Mats Rudling  Cell Metabolism 
Julian R. F. Walters, Ali M. Tasleem, Omer S. Omer, W
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Volume 15, Issue 1, Pages (January 2012)
Volume 142, Issue 7, Pages e6 (June 2012)
Homing in on bile acid physiology
Volume 129, Issue 2, Pages (August 2005)
Volume 14, Issue 5, Pages (November 2013)
Volume 20, Issue 7, Pages (August 2017)
Volume 102, Issue 6, Pages (September 2000)
Volume 22, Issue 2, Pages (August 2015)
Volume 120, Issue 5, Pages (April 2001)
Amani Al-Khaifi, Mats Rudling, Bo Angelin  Gastroenterology 
Volume 134, Issue 7, Pages (June 2008)
Volume 40, Issue 3, Pages (March 2004)
Volume 17, Issue 4, Pages (April 2013)
Volume 153, Issue 3, Pages (September 2017)
Volume 152, Issue 5, Pages e6 (April 2017)
Targeting the gut-liver axis in liver disease
Volume 20, Issue 5, Pages (November 2014)
Frank J. Gonzalez, Changtao Jiang, Andrew D. Patterson 
Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbα
Amir Zarrinpar, Amandine Chaix, Shibu Yooseph, Satchidananda Panda 
FGF21 Is an Exocrine Pancreas Secretagogue
Volume 12, Issue 4, Pages (October 2010)
Volume 12, Issue 2, Pages (August 2010)
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Volume 39, Issue 4, Pages (October 2003)
Volume 24, Issue 1, Pages (July 2016)
Volume 13, Issue 8, Pages (November 2015)
Volume 16, Issue 6, Pages (December 2014)
DCo(H2)ding the Metabolic Functions of SIRT1 in the Intestine
Volume 25, Issue 2, Pages (February 2017)
The Liver at the Nexus of Host-Microbial Interactions
Volume 16, Issue 5, Pages (November 2012)
Another Shp on the Horizon for Bile Acids
Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 
Volume 22, Issue 3, Pages (September 2015)
Volume 93, Issue 5, Pages (May 1998)
Microbes, Microbiota, and Colon Cancer
The NLR Protein NLRP6 Does Not Impact Gut Microbiota Composition
Volume 26, Issue 3, Pages e5 (September 2017)
Volume 1, Issue 2, Pages (February 2005)
Volume 17, Issue 6, Pages (June 2013)
Volume 7, Issue 1, Pages (April 2014)
Volume 21, Issue 5, Pages (May 2015)
Volume 22, Issue 6, Pages (December 2015)
Volume 62, Issue 6, Pages (June 2015)
Volume 7, Issue 3, Pages (March 2008)
Volume 6, Issue 3, Pages (September 2007)
Volume 21, Issue 3, Pages (March 2015)
Bo Angelin, Tobias E. Larsson, Mats Rudling  Cell Metabolism 
Volume 21, Issue 2, Pages (February 2015)
Volume 14, Issue 3, Pages (September 2013)
Volume 26, Issue 13, Pages e6 (March 2019)
Biliary Secretions August 3, 2019 Biliary Secretion.
Homing in on bile acid physiology
Figure 1 Bile acid biosynthesis, transport and metabolism
Volume 146, Issue 4, Pages e7 (April 2014)
Volume 19, Issue 6, Pages (May 2017)
Volume 16, Issue 6, Pages (December 2014)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 1, Issue 5, Pages (May 2005)
Presentation transcript:

Volume 17, Issue 2, Pages 225-235 (February 2013) Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta- muricholic Acid, a Naturally Occurring FXR Antagonist  Sama I. Sayin, Annika Wahlström, Jenny Felin, Sirkku Jäntti, Hanns-Ulrich Marschall, Krister Bamberg, Bo Angelin, Tuulia Hyötyläinen, Matej Orešič, Fredrik Bäckhed  Cell Metabolism  Volume 17, Issue 2, Pages 225-235 (February 2013) DOI: 10.1016/j.cmet.2013.01.003 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 The Gut Microbiota Alters the Size and Composition of the Total Bile Acid Pool (A) Total amount of bile acids in individual organs/tissues throughout the enterohepatic circulation and in the feces and serum of GF and CONV-R Swiss Webster mice. (B) Total amount of bile acids in the enterohepatic system obtained by combination of the values in (A). (C) Gallbladder weights of GF and CONV-R mice. Representative gallbladders are shown (inset). (D and E) Cholesterol (D) and phospholipids (E) in bile of GF and CONV-R mice. (F and G) ALP levels in serum (F) and histology of the gallbladder (G) in GF and CONV-R mice. Scale bars represent 20 μm. (GF mice weighed 30.2 ± 0.9 g and CONV-R mice 35.2 ± 0.8 g; p = 0.0007.) Mean values ± SEM are plotted; n = 14/group; ap < 0.05, bp < 0.01, cp < 0.001 versus GF, Student’s t test. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Specific Bile Acids in Individual Organs/Tissues throughout the Enterohepatic Circulation and in the Feces and Serum of GF and CONV-R Swiss Webster Mice n = 14/group. The bile acid profile in the small intestine shows the combined data from three segments (presented in Figure S2). Mean values ± SEM are plotted. ap < 0.05, bp < 0.01, cp < 0.001 versus GF, Student’s t test. CA, cholic acid; LCA, lithocholic acid; UDCA, ursodeoxycholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; MCA, muricholic acid; T, taurine-conjugated species. See also Figures S1–S3 and Table S2. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Bacterial Regulation of Genes Involved in Bile Acid Synthesis, Conjugation, and Reabsorption Gene expression of enzymes involved in bile acid biosynthesis (A), activity of CYP7A1 and CYP8B1 (B), taurine levels (C), and gene expression of enzymes and transporters involved in taurine biosynthesis and bile acid conjugation (D) in liver from GF and CONV-R Swiss Webster mice. Gene expression of bile acid transporters in the distal ileum (E) and liver (F) from GF and CONV-R mice. Mean values ± SEM are plotted; n = 8 mice/group; ap < 0.05, bp < 0.01, cp < 0.001 versus GF, Student’s t test. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Microbial and/or FXR Regulation of Genes Involved in Feedback Regulation of Bile Acid Synthesis (A and B) Expression of genes involved in bile acid homeostasis in the distal ileum (A) and liver (B) of wild-type (WT) and Fxr-deficient (Fxr−/−) mice raised as CONV-R or GF on a C57BL/6 genetic background. Mean values ± SEM are plotted; n = 4–8 mice/group. Expression of each gene is normalized to that of GF wild-type mice. Data were analyzed with two-way ANOVA followed by Bonferroni post hoc test: ∗p < 0.05,∗∗p < 0.01, ∗∗∗p < 0.001, significant for colonization. ap < 0.05, bp < 0.01, cp < 0.001, significant for genotype. #Significant for genotype-colonization interaction. (GF WT and Fxr−/− mice weighed 26.7 ± 1.4 g and 25.3 ± 1.3 g, respectively; CONV-R WT and Fxr−/− mice weighed 25.0 ± 1.3 g and 25.7 ± 2.4 g, respectively.) (C) Gene expression of ileal Fgf15 and hepatic Cyp7a1 expression in GF and CONV-R C57BL/6 mice treated with vehicle or INT-747 (n = 3–6 mice/group). Mean values ± SEM are plotted; dp < 0.05, ep < 0.01 versus control, Mann-Whitney U test. See also Figures S4–S7 and Table S1. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Antibiotic Treatment Modifies Bile Acid Composition and Regulates Gene Expression (A and B) Specific bile acid levels in the gallbladder (A) and serum (B) from CONV-R C57BL/6 mice treated with vehicle or a mixture of bacitracin, neomycin, and streptomycin. (C) Fgf15 expression in the ileum (left) and Cyp7a1 expression in the liver (right) from CONV-R mice treated with vehicle or a mixture of bacitracin, neomycin, and streptomycin. Mean values ± SEM are plotted; n = 3–8 mice/group; ap < 0.05, bp < 0.01, cp < 0.001 versus GF, one-way ANOVA. DCA, deoxycholic acid; MCA, muricholic acid; T, taurine-conjugated species. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Taurine-Conjugated MCAs Are Competitive FXR Antagonists (A) Docking of TβMCA (yellow) in the ligand-binding pocket of FXR using the FXR 6E-CDCA cocrystal structure (blue). (B) Coactivator recruitment assay to assess whether TαMCA and TβMCA are functional antagonists to CDCA (80 μM)-mediated activation of FXR. (C) Activation of FXR by GW4064 in the presence of 100 μM and 400 μM TβMCA to demonstrate reversibility of binding (assays were performed in triplicate and one out of two independent experiments is presented). (D) Fgf15 expression in ileal explants treated with TCA in the presence of different amounts of TβMCA. The assay was performed in explants derived from five independent mice. (E and F) Gene expression of Fgf15 (E) and Shp (F) in the ileum of GF C57BL/6 mice treated in vivo with TCA in the absence or presence of TβMCA (n = 6–7 mice/group). Data were analyzed with one-way ANOVA followed by Bonferroni post hoc test. Mean values ± SEM are plotted; ap < 0.05, bp < 0.01, cp < 0.001 versus control. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Model for Microbial Regulation of Bile Acid Metabolism GF mice have a larger total bile acid pool size compared with their CONV-R counterparts. The activity and expression of CYP7A1 and levels of TβMCA are increased in GF mice, whereas the expression and activity of CYP8B1 and levels of CA are similar in GF and CONV-R mice. TβMCA functions as a natural antagonist of FXR, which may result in reduced inhibition of CYP7A1 in GF mice. In CONV-R mice, the reduction in TβMCA leads to increased activation of FXR in enterocytes, which upregulates FGF15, a potential suppressor of CYP7A1 in the liver. Furthermore, the presence of the gut microbiota in the intestine of CONV-R mice causes variation in the bile acid profile due to the presence of secondary bile acids, as well as increased excretion of bile acids. Enzymes are indicated in gray. Cell Metabolism 2013 17, 225-235DOI: (10.1016/j.cmet.2013.01.003) Copyright © 2013 Elsevier Inc. Terms and Conditions